The Quantra Hemostasis System is the first & only viscoelastic testing platform FDA-cleared for obstetrics. It provides near-real-time, comprehensive assessment of a patient’s coagulation status, empowering clinicians with actionable data to help protect women at risk of postpartum hemorrhage during childbirth – the leading cause of maternal death.